Clinical Utility of Laboratory-Derived Risk Stratification Models for Assessing Disease Severity
ICME JOURNAL OF LABORATORY MEDICINE · 2026 · 7-8
DOI: 10.54646/icme.2026.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift ICME JOURNAL OF LABORATORY MEDICINE, 2026. Verfasst von Sheena Joe.
Abstract (Originalsprache)
Risk stratification is a fundamental component of clinical decision-making, enabling early identification of patients at risk of severe disease outcomes. Laboratory-derived risk stratification models utilize routinely available hematological and biochemical parameters to objectively assess disease severity and prognosis. These models have gained increasing importance due to their cost-effectiveness, reproducibility, and applicability across diverse clinical settings. This paper examines the clinical utility of laboratory-derived risk stratification models in assessing disease severity. It reviews commonly used laboratory biomarkers, methodological approaches for model development, and their applications in various disease conditions. The paper also discusses the advantages, limitations, and future potential of integrating laboratory-based models into routine clinical practice. Overall, laboratory derived risk stratification models represent a valuable tool for improving patient outcomes through timely intervention and evidence-based decision-making.
Zitieren
APA
Joe, S. (2026). Clinical Utility of Laboratory-Derived Risk Stratification Models for Assessing Disease Severity. ICME JOURNAL OF LABORATORY MEDICINE, 7-8. https://doi.org/10.54646/icme.2026.4
Vancouver
Joe S. Clinical Utility of Laboratory-Derived Risk Stratification Models for Assessing Disease Severity. ICME JOURNAL OF LABORATORY MEDICINE. 2026:7-8. doi:10.54646/icme.2026.4
BibTeX
@article{Joe2026,
author = {Joe, Sheena},
title = {Clinical Utility of Laboratory-Derived Risk Stratification Models for Assessing Disease Severity},
journal = {ICME JOURNAL OF LABORATORY MEDICINE},
year = {2026},
pages = {7--8},
doi = {10.54646/icme.2026.4}
}
EUVIMED